4A), suggesting that GLP-1R deletion resulted in reduced functional connectivity across the brain
This is a long-term treatment medication, not a one, two, or three month stint
The law (Medicare Modernization Act of 2003) explicitly excludes drugs when used for weight loss, weight gain, or anorexia. (ASPE) Some proposed changes (including reinterpreting the exclusion for obesity) were considered , but in April 2025 those were not finalized
However, it is an invasive, often painful procedure with significant cost and downtime
It curbs my appetite and gives me energy and I am loosing weight
These findings support the GLP-1 pathway as an alternative to impaired MC4R, offering a viable treatment